Audit 22102

FY End
2022-06-30
Total Expended
$285.91M
Findings
2
Programs
150
Organization: Wake Forest University (NC)
Year: 2022 Accepted: 2023-03-30
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
16626 2022-001 Significant Deficiency - AE
593068 2022-001 Significant Deficiency - AE

Programs

ALN Program Spent Major Findings
84.268 Federal Direct Student Loans $40.50M Yes 0
84.033 Federal Perkins Loan Program $9.27M Yes 0
93.RD Lung Organ Tissue Equivalent Platform for Modeling Chlorine Gas Toxicology $8.78M - 0
84.425 Education Stabilization Fund $3.84M Yes 0
84.181 Special Education-Grants for Infants and Families $3.33M - 0
84.063 Federal Pell Grant Program $2.54M Yes 0
98.001 Usaid Foreign Assistance for Programs Overseas $1.29M - 0
12.RD Determining the Fundamental Differences Among Tissue Organoids From Different Species $1.23M - 0
93.461 Covid-19 Testing for the Uninsured $1.07M Yes 1
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $774,017 - 0
93.RD Nc Corva Seq Network $755,715 - 0
93.RD Women Health Initiative - Regional Center $742,615 - 0
93.RD Applied Research to Address the Covid-19 Emerging Public $694,947 - 0
93.917 Hiv Care Formula Grants $688,191 - 0
84.007 Federal Supplemental Educational Opportunity Grants $645,078 Yes 0
93.RD Multi-Ethnic Study of Atherosclerosis (mesa) $575,714 - 0
20.RD Crash Injury Research Engineering Network Center $572,161 - 0
84.033 Federal Work-Study Program $550,114 Yes 0
12.340 Naval Medical Research and Development $543,880 - 0
12.RD Remdo Ati $468,301 - 0
93.RD Whims-Echo Hormone Therapy and Cognitive Aging in Older Postmenopausal Women $415,645 - 0
45.130 Promotion of the Humanities_challenge Grants $410,981 - 0
81.049 Office of Science Financial Assistance Program $407,361 - 0
93.RD Elc Project K8 Threat of Antibiotic-Resistant Gonorrhea $396,465 - 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $361,858 - 0
93.211 Telehealth Programs $264,105 - 0
47.050 Geosciences $259,610 - 0
93.RD Petal Network International Coordinatinc Center for Activ-3 Trial Initiative $236,050 - 0
59.075 Shuttered Venue Operators Grant Program $215,735 - 0
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $210,858 - 0
93.RD Multicenter Platform Evaluating Putative Therapeutics for the Treatment of Covid-19 in Hospitalized Adults $209,967 - 0
93.941 Hiv Demonstration, Research, Public and Professional Education Projects $208,626 - 0
93.RD Atherosclerosis Risk in Communities (aric) Field Center $206,382 - 0
93.945 Assistance Programs for Chronic Disease Prevention and Control $188,195 - 0
47.070 Computer and Information Science and Engineering $183,570 - 0
47.074 Biological Sciences $174,003 - 0
93.310 Trans-Nih Research Support $158,716 - 0
92.213 Research and Training in Complementary and Integrative Health $154,617 - 0
93.889 National Bioterrorism Hospital Preparedness Program $150,000 - 0
93.RD Covid-19 Post-Hospital Thrombosis Prevention Study $135,276 - 0
21.019 Coronavirus Relief Fund $126,980 - 0
93.107 Area Health Education Centers Point of Service Maintenance and Enhancement Awards $124,131 - 0
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $122,868 - 0
43.RD Science $116,629 - 0
93.RD Randomized Master Protocol for Immune Modulators $114,607 - 0
12.431 Basic Scientific Research $111,261 - 0
93.RD Enhanced Rapid Assay for Monitoring Immunosuppressant $110,460 - 0
47.076 Education and Human Resources $108,906 - 0
93.978 Preventive Health Services_sexually Transmitted Diseases Research, Demonstrations, and Public Information and Education Grants $100,754 - 0
93.RD Ivy: Covid-19 Ancillary Studies $93,618 - 0
93.RD Medical Imaging and Data Consortium $88,311 - 0
12.630 Basic, Applied, and Advanced Research in Science and Engineering $88,124 - 0
43.003 Exploration $82,458 - 0
93.394 Cancer Detection and Diagnosis Research $81,834 - 0
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nations Health $80,208 - 0
93.250 Geriatric Academic Career Awards Department of Health and Human Services (b) $71,475 - 0
93.334 The Healthy Brain Initiative: Technical Assistance to Implement Public Health Actions Related to Cognitive Health, Cognitive Impairment, and Caregiving at the State and Local Levels $70,073 - 0
93.350 National Center for Advancing Translational Sciences $67,987 - 0
45.164 Promotion of the Humanities_public Programs $65,637 - 0
93.RD Molecular Basis of Exercise-Induced Changes in Hdl Function $64,878 - 0
10.310 Agriculture and Food Research Initiative (afri) $63,758 - 0
12.RD Development of A Universal Bioreactor Platform for Regenerative Medicine Clinical Manufacturing $59,785 - 0
93.226 Research on Healthcare Costs, Quality and Outcomes $58,433 - 0
93.213 Research and Training in Complementary and Integrative Health $47,975 - 0
93.RD Optopharmacology and Sensors for Dissecting Opiate Actio $47,398 - 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $43,483 - 0
93.RD Whims Investigating the Biology of Cognitive Resilience $42,432 - 0
93.RD Chs Research for the Cardiovascular Health $40,743 - 0
12.RD Immunopathology, Fluorescent Imaging and Histomorphomet $40,108 - 0
93.RD Atherosclerosis Risk in Communities (aric) - Coordinating Center $37,490 - 0
93.RD Jackson Heart Surveillance Study (jhs Surveillance) $36,771 - 0
93.242 Mental Health Research Grants $36,729 - 0
93.103 Food and Drug Administration_research $35,691 - 0
93.865 Child Health and Human Development Extramural Research $35,688 - 0
47.075 Social, Behavioral, and Economic Sciences $32,912 - 0
93.351 Research Infrastructure Programs $32,486 - 0
93.279 Drug Abuse and Addiction Research Programs $32,250 - 0
12.RD Neocare Platform to Prolong Tissue Preservation $31,246 - 0
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $31,109 - 0
93.837 Cardiovascular Diseases Research $29,934 - 0
81.RD Directed Electrode Nanostructure Engineering $28,620 - 0
93.273 Alcohol Research Programs $28,536 - 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $27,040 - 0
93.866 Aging Research $26,701 - 0
93.859 Biomedical Research and Research Training $26,043 - 0
93.307 Minority Health and Health Disparities Research $25,091 - 0
93.121 Oral Diseases and Disorders Research $24,935 - 0
93.RD Impact of Nicotine Reduction on Adolescent Cigarette Use $24,835 - 0
93.924 Ryan White Hiv/aids Dental Reimbursement and Community Based Dental Partnership Grants $24,692 - 0
93.172 Human Genome Research $24,553 - 0
93.395 Cancer Treatment Research $23,358 - 0
93.124 Nurse Anesthetist Traineeships $22,326 - 0
93.867 Vision Research $20,268 - 0
93.RD A Randomized Phase Ii/iii Study of Conventional $20,259 - 0
93.359 Nurse Education, Practice Quality and Retention Grants $20,021 - 0
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $19,111 - 0
93.RD Department of Defense $17,643 - 0
93.839 Blood Diseases and Resources Research $17,492 - 0
93.RD Adaptive Platform Treatment Trial for Outpatients with Covid-19 (adapt Out Covid) $16,637 - 0
93.110 Maternal and Child Health Federal Consolidated Programs $16,291 - 0
47.041 Engineering $15,594 - 0
93.361 Nursing Research $15,584 - 0
93.RD Intergovernmental Personnel Act Mobility Program $15,570 - 0
93.RD Effectiveness of Ha Mrna-Lnp Vaccines in Newborn Nhp $15,539 - 0
93.113 Environmental Health $14,681 - 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $14,461 - 0
12.RD Assembly of Topologic $13,739 - 0
93.RD Cancer Research $13,198 - 0
93.397 Cancer Centers Support Grants $13,141 - 0
93.399 Cancer Control $12,897 - 0
93.RD Piedmont Triad Regional Council Area Agency on Aging $12,837 - 0
93.855 Allergy, Immunology and Transplantation Research $12,780 - 0
93.RD Change in Relative Cerebral Blood Volume As A Biomarker $12,726 - 0
93.RD Electronic Health Record (ehr)-Embedded Decision Support $12,650 - 0
93.989 International Research and Research Training $11,461 - 0
64.RD Collaboration for Developing A Virtual Reality App $11,198 - 0
93.398 Cancer Research Manpower $11,046 - 0
93.RD Characterizing Home Activity for Cancer Health Awareness (cha-Cha) $10,585 - 0
93.RD Covid-19 Imaging Research Registry (cirr) $10,440 - 0
93.RD Sexually Transmitted Infections Clinical Trials Group Admin Core $9,405 - 0
93.RD Phase III Trial of Stereotactic Radiosurgery (srs) $9,343 - 0
93.393 Cancer Cause and Prevention Research $9,148 - 0
93.879 Medical Library Assistance $9,129 - 0
93.RD Ai-Based Multi-Functional Hand-Held $9,108 - 0
93.RD Randomized Phase III Trial of Bortezomib Lenalidomide A $8,332 - 0
93.396 Cancer Biology Research $8,109 - 0
93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research $7,966 - 0
19.040 Public Diplomacy Programs $7,594 - 0
93.RD A Phase II Study of Inotuzmab Ozogamcin $7,501 - 0
93.RD Intergovernmental Personnel Act of 1970 $6,616 - 0
93.RD Adcc Passive Transfer and Dengue Virus Challenge $6,105 - 0
93.RD Evaluating Fitness-for-Use Electronic Health Records $5,379 - 0
93.838 Lung Diseases Research $5,371 - 0
93.RD Chips (chilled Platelet Study) $4,571 - 0
93.969 Pphf Geriatric Education Centers $4,511 - 0
93.RD Randomized Phase III Study of Ibrutinib (pci-32765)-Based Therapy $4,477 - 0
93.RD Optimal Perioperative Therapy for Incidental Gallbladder $3,974 - 0
93.173 Research Related to Deafness and Communication Disorders $3,707 - 0
66.509 Science to Achieve Results (star) Research Program $3,667 - 0
47.049 Mathematical and Physical Sciences $3,576 - 0
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $2,160 - 0
93.RD Phase III Trial of Salvage Stereotactic Radiosurgery $1,999 - 0
93.262 Occupational Safety and Health Program $1,336 - 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $1,301 - 0
12.RD Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring $1,002 - 0
93.073 Birth Defects and Developmental Disabilities - Prevention and Surveillance $868 - 0
12.420 Military Medical Research and Development $543 - 0
93.RD Clinical-Trial of Covid-19 Convalescent Plasma in Outpatience (c3po) $388 - 0
47.073 Office of Science and Technology Infratructure Programs $44 - 0
12.300 Basic and Applied Scientific Research $5 - 0

Contacts

Name Title Type
MBU6HCLNZ431 Marnie Matthews Auditee
3367583201 Jennifer Hall Auditor
No contacts on file

Notes to SEFA

Title: (3) Summary of Facilities and Administrative Costs and Administrative Cost Accounting Policies: (1)Basis of PresentationThe accompanying schedule of expenditures of federal awards (the schedule) includes all grants, contracts, and similar agreements entered into directly between Wake Forest University (the University) and agencies and departments of the federal government and all subawards to the University by nonfederal organizations pursuant to federal grants, contracts, and similar agreements and is presented on the accrual basis of accounting. The information in the schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in the schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements.The accompanying schedule of expenditures of state awards includes all grants, contracts, and similar agreements entered into directly between the University and agencies and departments of the state government and all subawards to the University by nonfederal organizations pursuant to state grants, contracts, and similar agreements and is presented on the accrual basis of accounting. (2) Summary of Significant Accounting PoliciesExpenditures for certain federal student financial aid programs are recognized as incurred and include the federal share of students Federal Supplemental Educational Opportunity Grant (FSEOG) program grants and Federal Work Study (FWS) program earnings, Pell grants, loan disbursements, and administrative cost allowances, where applicable.Expenditures for other federal awards of the Universitys academic and other divisions are recognized following, as applicable, either the cost principles in OMB Circular A-21, Cost Principles for Educational Institutions, or the cost principles contained in Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, wherein certain types of expenditures are not allowable or are limited as to reimbursement.Expenditures for non-financial aid awards include indirect costs, related primarily to facilities operation and maintenance and general, divisional, and departmental administrative services, which are allocated to direct cost objectives (including federal awards) based on negotiated formulas commonly referred to as facilities and administrative cost rates. Facilities and administrative costs allocated to such awards for the year ended June 30, 2022 were based on predetermined rates negotiated with the Universitys cognizant federal agency, the U.S. Department of Health and Human Services. The University has elected not to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance.Negative balances presented in the schedule represent programs with unfunded expenditures prior to normal close-out procedures, which were subsequently transferred to nonfederal cost centers. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. Facilities and administrative cost recoveries and administrative cost allowances for the Universitys academic and other divisions for the year ended June 30, 2022 are summarized as follows: Research and development $49,633,979 Student financial aid $36,442; Total $49,670,421
Title: (4) Federal Student Financial Aid Loan Programs Accounting Policies: (1)Basis of PresentationThe accompanying schedule of expenditures of federal awards (the schedule) includes all grants, contracts, and similar agreements entered into directly between Wake Forest University (the University) and agencies and departments of the federal government and all subawards to the University by nonfederal organizations pursuant to federal grants, contracts, and similar agreements and is presented on the accrual basis of accounting. The information in the schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in the schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements.The accompanying schedule of expenditures of state awards includes all grants, contracts, and similar agreements entered into directly between the University and agencies and departments of the state government and all subawards to the University by nonfederal organizations pursuant to state grants, contracts, and similar agreements and is presented on the accrual basis of accounting. (2) Summary of Significant Accounting PoliciesExpenditures for certain federal student financial aid programs are recognized as incurred and include the federal share of students Federal Supplemental Educational Opportunity Grant (FSEOG) program grants and Federal Work Study (FWS) program earnings, Pell grants, loan disbursements, and administrative cost allowances, where applicable.Expenditures for other federal awards of the Universitys academic and other divisions are recognized following, as applicable, either the cost principles in OMB Circular A-21, Cost Principles for Educational Institutions, or the cost principles contained in Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, wherein certain types of expenditures are not allowable or are limited as to reimbursement.Expenditures for non-financial aid awards include indirect costs, related primarily to facilities operation and maintenance and general, divisional, and departmental administrative services, which are allocated to direct cost objectives (including federal awards) based on negotiated formulas commonly referred to as facilities and administrative cost rates. Facilities and administrative costs allocated to such awards for the year ended June 30, 2022 were based on predetermined rates negotiated with the Universitys cognizant federal agency, the U.S. Department of Health and Human Services. The University has elected not to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance.Negative balances presented in the schedule represent programs with unfunded expenditures prior to normal close-out procedures, which were subsequently transferred to nonfederal cost centers. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. The Federal Perkins Loan, Health Professions Student Loan (HPSL), and the Primary Care Loan (PCL) programs are administered directly by the University and balances and transactions relating to these programs are included in the Universitys consolidated financial statements. There were no current year loaned amounts under the Federal Perkins Loan program, the HSPL or PCL programs. The balance of loans outstanding under the Federal Perkins Loan program was $7,061,520 as of June 30, 2022. There were no loans outstanding for the HPSL and PCL programs as of June 30, 2022.The University disbursed the following amounts of new loans under the Federal Direct Student Loan Program to students of the University during the year ended June 30, 2022: Federal Direct Student Loan Program: Federal subsidized stafford loans $2,212,323 Federal unsubsidized stafford loans 43,107,667 Federal PLUS loans 34,591,320; Total $79,911,310 The University is responsible only for the performance of certain administrative duties with respect to the Federal Direct Student Loan Program and, accordingly, these loans are not included in its basic financial statements. It is not practicable to determine the balance of loans outstanding to students and former students of the University under these programs as of June 30, 2022.
Title: (5) Matching Accounting Policies: (1)Basis of PresentationThe accompanying schedule of expenditures of federal awards (the schedule) includes all grants, contracts, and similar agreements entered into directly between Wake Forest University (the University) and agencies and departments of the federal government and all subawards to the University by nonfederal organizations pursuant to federal grants, contracts, and similar agreements and is presented on the accrual basis of accounting. The information in the schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in the schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements.The accompanying schedule of expenditures of state awards includes all grants, contracts, and similar agreements entered into directly between the University and agencies and departments of the state government and all subawards to the University by nonfederal organizations pursuant to state grants, contracts, and similar agreements and is presented on the accrual basis of accounting. (2) Summary of Significant Accounting PoliciesExpenditures for certain federal student financial aid programs are recognized as incurred and include the federal share of students Federal Supplemental Educational Opportunity Grant (FSEOG) program grants and Federal Work Study (FWS) program earnings, Pell grants, loan disbursements, and administrative cost allowances, where applicable.Expenditures for other federal awards of the Universitys academic and other divisions are recognized following, as applicable, either the cost principles in OMB Circular A-21, Cost Principles for Educational Institutions, or the cost principles contained in Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, wherein certain types of expenditures are not allowable or are limited as to reimbursement.Expenditures for non-financial aid awards include indirect costs, related primarily to facilities operation and maintenance and general, divisional, and departmental administrative services, which are allocated to direct cost objectives (including federal awards) based on negotiated formulas commonly referred to as facilities and administrative cost rates. Facilities and administrative costs allocated to such awards for the year ended June 30, 2022 were based on predetermined rates negotiated with the Universitys cognizant federal agency, the U.S. Department of Health and Human Services. The University has elected not to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance.Negative balances presented in the schedule represent programs with unfunded expenditures prior to normal close-out procedures, which were subsequently transferred to nonfederal cost centers. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. Under the FWS program, the University did not match any compensation to students for the year ended June 30, 2022.Under the FSEOG program, the University matched $236,455 in funds awarded to students for the year ended June 30, 2022 in addition to the federal share of expenditures in the accompanying schedule.

Finding Details

Finding No. 2022-001: Allowability and Eligibility Federal Program: COVID-19 ? Claims Reimbursement Program for the Uninsured for the COVID-19 Coverage Assistance FundCriteria or Requirement(ALN 93.461) Federal Award Year: July 1, 2021 through June 30, 2022 Federal Award Agency U.S. Department of Health and Human Services Ciiteria or RequirementPer the terms and conditions of the award, the recipient certifies that the patients identified on the claim form were uninsured individuals at the time the services were provided. Per 2 CFR 200.303, the nonfederal entity must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the nonfederal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. Condition Found, Including Perspective For 2 out of 40 patients sampled, the patient had Medicaid or other insurance coverage that was applied subsequently, for the time-period of services provided. Wake Forest University Health Sciences did not refund Health Resources and Services Administration (HRSA) for the amount that was paid on these claims. The amount paid on these claims was $1,504 and the sampled population was $7,551. Possible Cause and Asserted Effect Wake Forest University Health Science?s internal controls failed to prevent the subsequently identified insurance coverage from being added as secondary coverage to HRSA and therefore, the patient claim was submitted to and reimbursed by HRSA and not refunded. Questioned Costs $1,504 Statistical Validity The sample was not intended to be, and was not, a statistically valid sample. Repeat Finding in the Prior Year No. Recommendation We recommend the University enhance the precision of the control around timely identification of coverages added subsequent to the normal control process (but applies to earlier dates of service) which would require refund to HRSA.
Finding No. 2022-001: Allowability and Eligibility Federal Program: COVID-19 ? Claims Reimbursement Program for the Uninsured for the COVID-19 Coverage Assistance FundCriteria or Requirement(ALN 93.461) Federal Award Year: July 1, 2021 through June 30, 2022 Federal Award Agency U.S. Department of Health and Human Services Ciiteria or RequirementPer the terms and conditions of the award, the recipient certifies that the patients identified on the claim form were uninsured individuals at the time the services were provided. Per 2 CFR 200.303, the nonfederal entity must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the nonfederal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. Condition Found, Including Perspective For 2 out of 40 patients sampled, the patient had Medicaid or other insurance coverage that was applied subsequently, for the time-period of services provided. Wake Forest University Health Sciences did not refund Health Resources and Services Administration (HRSA) for the amount that was paid on these claims. The amount paid on these claims was $1,504 and the sampled population was $7,551. Possible Cause and Asserted Effect Wake Forest University Health Science?s internal controls failed to prevent the subsequently identified insurance coverage from being added as secondary coverage to HRSA and therefore, the patient claim was submitted to and reimbursed by HRSA and not refunded. Questioned Costs $1,504 Statistical Validity The sample was not intended to be, and was not, a statistically valid sample. Repeat Finding in the Prior Year No. Recommendation We recommend the University enhance the precision of the control around timely identification of coverages added subsequent to the normal control process (but applies to earlier dates of service) which would require refund to HRSA.